Ipratropium Bromide and Albuterol Sulfate (Cipla USA Inc.)
Welcome to the PulseAid listing for the Ipratropium Bromide and Albuterol Sulfate drug offered from Cipla USA Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | Ipratropium Bromide and Albuterol Sulfate |
| SUBSTANCE NAME: | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2007-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide and Albuterol Sulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ipratropium Bromide and Albuterol Sulfate from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; .5(mg/3mL; mg/3mL) |
| START MARKETING DATE: | 2007-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-173_f8476423-eeb4-4ffd-9355-12d19a8f0ca7 |
| PRODUCT NDC: | 69097-173 |
| APPLICATION NUMBER: | ANDA077559 |
Other ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers:
